JPS6154031B2 - - Google Patents

Info

Publication number
JPS6154031B2
JPS6154031B2 JP1951278A JP1951278A JPS6154031B2 JP S6154031 B2 JPS6154031 B2 JP S6154031B2 JP 1951278 A JP1951278 A JP 1951278A JP 1951278 A JP1951278 A JP 1951278A JP S6154031 B2 JPS6154031 B2 JP S6154031B2
Authority
JP
Japan
Prior art keywords
group
tert
add
formula
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP1951278A
Other languages
Japanese (ja)
Other versions
JPS54112867A (en
Inventor
Masaru Iwanami
Kazuharu Tamazawa
Kyoshi Murase
Tadao Shibanuma
Kensho Nagano
Masaharu Fujimoto
Tetsuya Maeda
Yoshinobu Nagano
Atsuki Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yamanouchi Pharmaceutical Co Ltd
Original Assignee
Yamanouchi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharmaceutical Co Ltd filed Critical Yamanouchi Pharmaceutical Co Ltd
Priority to JP1951278A priority Critical patent/JPS54112867A/en
Priority to GB25352/78A priority patent/GB1604738A/en
Priority to DE2824575A priority patent/DE2824575C2/en
Priority to CH610878A priority patent/CH636098A5/en
Priority to US05/913,501 priority patent/US4198339A/en
Priority to FR7817304A priority patent/FR2398745A1/en
Priority to IT68370/78A priority patent/IT1109095B/en
Publication of JPS54112867A publication Critical patent/JPS54112867A/en
Priority to US06/304,986 priority patent/US4414153A/en
Publication of JPS6154031B2 publication Critical patent/JPS6154031B2/ja
Priority to US07/449,114 priority patent/USRE33778E/en
Granted legal-status Critical Current

Links

Landscapes

  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は一般式() 〔式中R1はカルボキシル基、シアノ基、ベンズヒ
ドリルオキシカルボニル基又は低級アルコキシカ
ルボニル基を、R2は水素原子、シアノ基、カル
ボキシル基、スルフアモイル基、ビニル基、置換
されていてもよいカルバモイル基、低級アルキル
基、低級アルコキシ基、アロイル基、置換されて
いてもよいアリール基、置換されていてもよい単
環複素環基、RCO―又はR―S(O)o―(式中
Rは低級アルコキシ基、又は水酸基を有していて
もよくまたヘテロ原子で中断されていてもよい低
級アルキル基を、nは0,1又は2を表わす。)
で示される基を、R3は水素原子又は低級アルキ
ル基を表わす。〕 で示される1,3―ジチエタン化合物及びその製
造法に関する。 ここに低級アルキル基とは、メチル基、エチル
基、イソプロピル基、ブチル基、tert―ブチル
基、ヘキシル基等の炭素数1〜6個の直鎖又は分
枝状のものを意味し、低級アルコキシ基とは、メ
トキシ基、エトキシ基、イソプロポキシ基、ブト
キシ基、tert―ブトキシ基等の炭素数1〜6個の
直鎖又は分枝状のものを意味する。また単環複素
環基とは、ピロリル基、ピロリジニル基、イミダ
ゾリル基、チエニル基、チアジアゾリル基、ピリ
ジル基、ピペリジノ基等のイオウ原子及び/又は
窒素原子を含む5又は6員環基を意味する。また
アロイル基としては、例えばベンゾイル基等が挙
げられ、アリール基としては、例えばフエニル
基、ナフチル基等が挙げられる。また置換されて
いてもよいカルバモイル基としては、例えば水酸
基、低級アルキル基、ジ低級アルキル基等で置換
されたカルバモイル基及び未置換のカルバモイル
基等が挙げられる。さらに前記単環複素環基及び
アリール基は、水酸基、低級アルコキシ基、低級
アルキル基、低級アルキルチオ基等で置換されて
いてもよい。 本発明化合物()は文献未載の新規な化合物
であつて、一般式() (式中R1とR2は前記と同じ意味を表わし、R4は水
素原子又はメトキシ基を、R5は水酸基を有して
いてもよくまたヘテロ原子で中断されていてもよ
い低級アルキル基を表わす。) で示されるセフアロスポリン化合物の原料として
有用である。このセフアロスポリン化合物は7位
に置換ジチエタンカルボン酸アミド残基を有する
特異な化学構造を有し、新規でかつ坑菌作用を有
する有用な化合物であり、例えば本発明化合物
()と一般式() (式中R4とR5は前記と同じ意味を表わす。) で示される7β―アミノセフアロスポリン化合物
とを反応させることによつて製造することができ
る。 本発明化合物()は、一般式() (式中R1とR2は前記と同じ意味を表わす。) で示されるエチレンジチオール化合物と 一般式() (式中Xはハロゲン原子を表わし、R3は前記と同
じ意味を表わす。) で示されるジハロゲノ酢酸化合物とを反応させる
ことによつて製造することができる。 この反応は、化合物()とそれと等モル乃至
過剰モルの化合物()を用いて反応に関与しな
い有機溶媒中、塩素の存在下で冷却下乃至加熱下
で行なうのが好ましい。反応に関与しない有機溶
媒としては例えばメタノール、エタノール、ブタ
ノール、tert―ブタノール、クロロホルム、塩化
メチレン、テトラヒドロフラン、ベンゼン、トル
エン、ジメトキシエタン、アニソール、アセト
ン、ジメトキシエタン、ジメチルスルホキシド、
ジメチルホルムアミド、ジメチルアニリン等が挙
げられ、塩基としては例えばピリジン、トリエチ
ルアミン、ジシクロヘキシルアミン、アルカリ金
属(金属カリウム等)、水素化アルカリ金属(水
素化ナトリウム、水素化カリウム等)、アルキル
リチウム(メチルリチウム、tert―ブチルリチウ
ム等)、炭酸ナトリウム、炭酸カリウム、リチウ
ムジイソプロピルアミン等が挙げられる。 この反応で用いられる化合物()におけるハ
ロゲン原子としては、塩素原子、臭素原子及びヨ
ード原子が好ましく、また化合物()において
R3が水素原子のときはそのアルカリ塩、例えば
ナトリウム塩、カリウム塩等を用いることができ
る。 化合物()においてR3が低級アルキル基で
ある場合は前記有機溶媒中、塩酸、酢酸、トリフ
ルオロ酢酸等の酸の存在下加水分解することによ
つてR3が水素原子である化合物()を得るこ
とができる。また化合物()においてR2がカ
ルバモイル基である場合は、前記有機溶媒中で無
機塩化物、例えばオキシ塩化リン、五塩化リン、
塩化チオニル、塩化スルフリル等の存在下脱水反
応を行なうことによつてシアノ基に変換すること
ができる。 本発明で原料として用いられるエチレンジオー
ル化合物()は公知物のみならず新規なものも
含んでおり、それらは例えば一般式() R1―CH2―R2 () (式中R1とR2は前記と同じ意味を有する。) で示される化合物と二硫化炭素とを前記有機溶媒
中、同じく前記塩基の存在下、冷却下乃至加熱下
で反応させることによつて製造することができ
る。 以下本発明化合物の具体的な構造を実施例によ
つて説明する。 実施例 1 ジナトリウム2,2―ビス(メトキシカルボニ
ル)エチレン―1,1―ジチオレート2.1gを無
水テトラヒドロフラン10mlに懸濁し、次いでジブ
ロモ酢酸ナトリウム2.2gを加え室温で2時間か
きまぜる。反応液の溶媒を減圧留去し、残留物を
水5mlに溶かし、希塩酸でPH3.5〜4.0にした後、
酢酸エチルで抽出する。抽出液を無水硫酸マグネ
シウムで乾燥後、溶媒を減圧留去し、残留物にエ
ーテルを加えて過すると4―〔ビス(メトキシ
カルボニル)メチレン〕―1,3―ジチエタン―
2―カルボン酸1.5gが得られる。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm);3.70(6H,
The present invention is based on the general formula () [In the formula, R 1 is a carboxyl group, a cyano group, a benzhydryloxycarbonyl group, or a lower alkoxycarbonyl group, and R 2 is a hydrogen atom, a cyano group, a carboxyl group, a sulfamoyl group, a vinyl group, or an optionally substituted carbamoyl group. group, lower alkyl group, lower alkoxy group, aroyl group, optionally substituted aryl group, optionally substituted monocyclic heterocyclic group, RCO- or R-S(O) o- (wherein R is (n represents a lower alkoxy group or a lower alkyl group which may have a hydroxyl group or may be interrupted by a hetero atom; n represents 0, 1 or 2)
In the group represented by, R 3 represents a hydrogen atom or a lower alkyl group. ] The present invention relates to a 1,3-dithiethane compound represented by the following and a method for producing the same. The term "lower alkyl group" herein refers to a linear or branched group having 1 to 6 carbon atoms, such as a methyl group, ethyl group, isopropyl group, butyl group, tert-butyl group, hexyl group, etc. The group means a straight chain or branched group having 1 to 6 carbon atoms, such as a methoxy group, an ethoxy group, an isopropoxy group, a butoxy group, and a tert-butoxy group. Moreover, the monocyclic heterocyclic group means a 5- or 6-membered ring group containing a sulfur atom and/or a nitrogen atom, such as a pyrrolyl group, a pyrrolidinyl group, an imidazolyl group, a thienyl group, a thiadiazolyl group, a pyridyl group, and a piperidino group. Examples of the aroyl group include a benzoyl group, and examples of the aryl group include a phenyl group and a naphthyl group. Examples of the optionally substituted carbamoyl group include a carbamoyl group substituted with a hydroxyl group, a lower alkyl group, a di-lower alkyl group, and an unsubstituted carbamoyl group. Further, the monocyclic heterocyclic group and the aryl group may be substituted with a hydroxyl group, a lower alkoxy group, a lower alkyl group, a lower alkylthio group, or the like. The compound of the present invention () is a novel compound that has not been described in any literature, and has the general formula () (In the formula, R 1 and R 2 represent the same meanings as above, R 4 is a hydrogen atom or a methoxy group, and R 5 is a lower alkyl group which may have a hydroxyl group or may be interrupted by a hetero atom. It is useful as a raw material for the cephalosporin compound represented by This cephalosporin compound has a unique chemical structure with a substituted dithiethanecarboxylic acid amide residue at the 7-position, and is a novel and useful compound with antibacterial activity.For example, the compound of the present invention () and the general formula () (In the formula, R 4 and R 5 have the same meanings as above.) It can be produced by reacting with a 7β-aminocephalosporin compound represented by the following formula. The compound of the present invention () has the general formula () (In the formula, R 1 and R 2 have the same meanings as above.) Ethylene dithiol compound represented by the general formula () (In the formula, X represents a halogen atom, and R 3 represents the same meaning as above.) It can be produced by reacting with a dihalogenoacetic acid compound represented by the following formula. This reaction is preferably carried out using Compound () and an equimolar to excess molar amount of Compound () in an organic solvent that does not participate in the reaction, in the presence of chlorine, and under cooling or heating. Examples of organic solvents that do not participate in the reaction include methanol, ethanol, butanol, tert-butanol, chloroform, methylene chloride, tetrahydrofuran, benzene, toluene, dimethoxyethane, anisole, acetone, dimethoxyethane, dimethyl sulfoxide,
Examples of bases include pyridine, triethylamine, dicyclohexylamine, alkali metals (metallic potassium, etc.), alkali metal hydrides (sodium hydride, potassium hydride, etc.), alkyllithium (methyllithium, etc.), and dimethylformamide, dimethylaniline, etc. tert-butyllithium, etc.), sodium carbonate, potassium carbonate, lithium diisopropylamine, etc. The halogen atom in the compound () used in this reaction is preferably a chlorine atom, a bromine atom, or an iodo atom;
When R 3 is a hydrogen atom, its alkali salts such as sodium salts and potassium salts can be used. When R 3 is a lower alkyl group in the compound (), the compound () in which R 3 is a hydrogen atom can be obtained by hydrolysis in the organic solvent in the presence of an acid such as hydrochloric acid, acetic acid, or trifluoroacetic acid. Obtainable. In addition, when R 2 is a carbamoyl group in the compound (), an inorganic chloride, such as phosphorus oxychloride, phosphorus pentachloride,
It can be converted to a cyano group by carrying out a dehydration reaction in the presence of thionyl chloride, sulfuryl chloride, or the like. The ethylenediol compound () used as a raw material in the present invention includes not only known compounds but also new ones, and these include, for example, the general formula () R 1 --CH 2 --R 2 () (in the formula, R 1 and R 2 has the same meaning as above.) It can be produced by reacting the compound represented by (2) with carbon disulfide in the organic solvent, also in the presence of the base, under cooling or heating. The specific structures of the compounds of the present invention will be explained below using Examples. Example 1 2.1 g of disodium 2,2-bis(methoxycarbonyl)ethylene-1,1-dithiolate is suspended in 10 ml of anhydrous tetrahydrofuran, then 2.2 g of sodium dibromoacetate is added and stirred at room temperature for 2 hours. The solvent of the reaction solution was distilled off under reduced pressure, the residue was dissolved in 5 ml of water, and the pH was adjusted to 3.5 to 4.0 with dilute hydrochloric acid.
Extract with ethyl acetate. After drying the extract over anhydrous magnesium sulfate, the solvent was distilled off under reduced pressure, and the residue was filtered with ether to give 4-[bis(methoxycarbonyl)methylene]-1,3-dithiethane-
1.5 g of 2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm); 3.70 (6H,

【式】) 5.20(1H,【formula】) 5.20 (1H,

【式】) 実施例 2 ジナトリウム2,2―ビス(tert―ブトキシカ
ルボニル)エチレン―1,1―ジチオレートを実
施例1と同様に処理することにより、4―〔ビス
(tert―ブトキシカルボニル)メチレン〕―1,
3―ジチエタン―2―カルボン酸を得る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm);1.46(18H,20(CH33COOC―) 5.18(1H,
[Formula]) Example 2 By treating disodium 2,2-bis(tert-butoxycarbonyl)ethylene-1,1-dithiolate in the same manner as in Example 1, 4-[bis(tert-butoxycarbonyl)methylene]-1,
3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm); 1.46 (18H, 20(CH 3 ) 3 COOC-) 5.18 (1H,

【式】) 実施例 3 tort―ブトキシカリウム15%含有tert―ブタノ
ール溶液15.6g中に、室温でかきまぜながら、フ
エニル酢酸tort―ブチル4g、次いで二硫化炭素
1.6gを加える。15分間かきまぜた後、無水テト
ラヒドロフラン20ml、さらにtert―ブトキシカリ
ウム15%含有tert―ブタノール溶液31.2gを加
え、次いでジクロロ酢酸2.7gを30〜40℃で適下
し、同温度で30分間かきまぜて反応を終る。反応
液が弱アルカリ性になるまでジクロロ酢酸を加え
た後、溶媒を減圧留去し、氷水を加えてエーテル
で洗浄する。次に3規定塩酸0.5mlを加え、エー
テルで抽出し、さらに3規定塩酸0.5mlを加え、
エーテルで抽出、この操作をくり返し、得られる
各抽出フラクシヨンをシリカゲル薄層クロマトグ
ラフイーで追跡して目的物を含むフラクシヨンを
集め無水硫酸マグネシウムで乾燥する。次に溶媒
を減圧留去すると4―(α―tert―ブトキシカル
ボニルベンジリデン)―1,3―ジチエタン―2
―カルボン酸約1gが得られる。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm);1.40(9H,(CH33COOC―) 5.17(1H,
[Formula]) Example 3 In 15.6 g of a tert-butanol solution containing 15% potassium tort-butoxy, 4 g of tort-butyl phenyl acetate was added, followed by carbon disulfide, while stirring at room temperature.
Add 1.6g. After stirring for 15 minutes, add 20 ml of anhydrous tetrahydrofuran and 31.2 g of a tert-butanol solution containing 15% tert-butoxypotassium, then drop 2.7 g of dichloroacetic acid at 30-40°C, and stir at the same temperature for 30 minutes to react. end. After adding dichloroacetic acid until the reaction mixture becomes slightly alkaline, the solvent is distilled off under reduced pressure, ice water is added, and the mixture is washed with ether. Next, add 0.5ml of 3N hydrochloric acid, extract with ether, add 0.5ml of 3N hydrochloric acid,
Extract with ether, repeat this operation, track each extracted fraction obtained by silica gel thin layer chromatography, collect fractions containing the target product, and dry over anhydrous magnesium sulfate. Next, when the solvent was distilled off under reduced pressure, 4-(α-tert-butoxycarbonylbenzylidene)-1,3-dithiethane-2
-About 1 g of carboxylic acid is obtained. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm); 1.40 (9H, (CH 3 ) 3 COOC-) 5.17 (1H,

【式】) 約7.30(5H,【formula】) Approximately 7.30 (5H,

【式】) 実施例 4 4―tert―ブトキシフエニル酢酸tert―ブチル
を実施例3と同様に処理することにより、4―
(4―tert―ブトキシ―α―tert―ブトキシカルボ
ニルベンジリデン)―1,3―ジチエタン―2―
カルボン酸を得る。
[Formula]) Example 4 By treating tert-butyl 4-tert-butoxyphenylacetate in the same manner as in Example 3, 4-
(4-tert-butoxy-α-tert-butoxycarbonylbenzylidene)-1,3-dithiethane-2-
Obtain carboxylic acid.

【表】【table】

【表】 実施例 5 ジメチルカルバモイル酢酸tert―ブチルを実施
例3と同様に処理することにより、4―〔(tert
―ブトキシカルボニル)(ジメチルカルバモイ
ル)メチレン〕―1,3―ジチエタン―2―カル
ボン酸を得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm);1.50(9H,(CH33COOC―) 3.02(6H,
[Table] Example 5 By treating tert-butyl dimethylcarbamoylacetate in the same manner as in Example 3, 4-[(tert
-butoxycarbonyl)(dimethylcarbamoyl)methylene]-1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm); 1.50 (9H, (CH 3 ) 3 COOC—) 3.02 (6H,

【式】) 4.97(1H,【formula】) 4.97 (1H,

【式】) 実施例 6 3―ピリジル酢酸tert―ブチルを実施例3と同
様に処理することにより、4―〔(tert―ブトキ
シカルボニル)(3―ピリジル)メチレン〕―
1,3―ジチエタン―2―カルボン酸を得る。
[Formula]) Example 6 By treating tert-butyl 3-pyridylacetate in the same manner as in Example 3, 4-[(tert-butoxycarbonyl)(3-pyridyl)methylene]-
1,3-dithiethane-2-carboxylic acid is obtained.

【表】 実施例 7 3―ブテン酸tert―ブチルを実施例3と同様に
処理することにより、4―(1―tert―ブトキシ
カルボニル―2―プロペン―1―イリデン)―
1,3―ジチエタン―2―カルボン酸を得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm);1.51(9H,(CH33COOC―) 4.98(1H,
[Table] Example 7 By treating tert-butyl 3-butenoate in the same manner as in Example 3, 4-(1-tert-butoxycarbonyl-2-propene-1-ylidene)-
1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm); 1.51 (9H, (CH 3 ) 3 COOC—) 4.98 (1H,

【式】) 5.00〜5.40(2H,CH2 =CH―) 6.10〜6.50(1H,CH2=C―) 実施例 8 水素化ナトリウム(油性50%)4.8gをtert―
ブタノール150mlに加え、次いでアセト酢酸tert
―ブチル15.8gを少しづつ加える。これに二硫化
炭素7.6gを氷冷下加え、室温で18時間かきまぜ
る。次に水素化ナトリウム(油性50%)4.8gを
氷冷下少しづつ加え、室温で2時間かきまぜた
後、ジクロロ酢酸カリウム16.7gを加えてさらに
2時間かきまぜる。得られる反応液を減圧濃縮
し、酢酸エチル300mlと氷水200mlを加え、1規定
塩酸PH3〜4にし、有機層を塩化ナトリウム水溶
液で洗浄した後、飽和炭酸水素ナトリウム水溶液
で抽出する。この炭酸水素ナトリウム抽出液を酢
酸エチル50mlで洗浄し、1規定塩酸でPH3〜4と
し、酢酸エチル200mlで抽出する。この酢酸エチ
ル抽出液を塩化ナトリウム水溶液で洗浄し、無水
硫酸ナトリウムで乾燥後濃縮する。残留物を石油
エーテル・エーテル混液(容量比10:1)50mlで
洗浄後、エーテル5mlに溶かし、石油エーテル50
mlを少しづつ加えて析出する結晶を取すると4
―〔(アセチル)(tert―ブトキシカルボニル)メ
チレン〕―1,3―ジチエタン―2―カルボン酸
10gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.53(9H,(CH33COOC―) 2.49(3H,CH3OC―) 4.94(1H,
[Formula]) 5.00 to 5.40 (2H, CH 2 = CH -) 6.10 to 6.50 (1H, CH 2 = CH -) Example 8 4.8g of sodium hydride (50% oily)
Add to 150ml of butanol, then acetoacetic acid tert.
- Add 15.8g of butyl little by little. Add 7.6 g of carbon disulfide to this under ice cooling, and stir at room temperature for 18 hours. Next, add 4.8 g of sodium hydride (50% oily) little by little under ice cooling, stir at room temperature for 2 hours, then add 16.7 g of potassium dichloroacetate and stir for another 2 hours. The resulting reaction solution is concentrated under reduced pressure, 300 ml of ethyl acetate and 200 ml of ice water are added to adjust the pH to 1N hydrochloric acid from 3 to 4, the organic layer is washed with an aqueous sodium chloride solution, and then extracted with a saturated aqueous sodium bicarbonate solution. This sodium bicarbonate extract is washed with 50 ml of ethyl acetate, adjusted to pH 3-4 with 1N hydrochloric acid, and extracted with 200 ml of ethyl acetate. This ethyl acetate extract is washed with an aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and concentrated. After washing the residue with 50 ml of petroleum ether/ether mixture (volume ratio 10:1), dissolve in 5 ml of ether and add 50 ml of petroleum ether.
When adding ml little by little and removing the crystals that precipitate, 4
-[(acetyl)(tert-butoxycarbonyl)methylene]-1,3-dithiethane-2-carboxylic acid
Get 10g. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.53 (9H, (CH 3 ) 3 COOC—) 2.49 (3H, CH 3 OC—) 4.94 (1H,

【式】) 実施例 9 金属カリウム1.58gをtert―ブタノール100ml
に溶かし、5―メチルチオ―1,3,4―チアジ
アゾール―2―酢酸tert―ブチル10gを加えて20
分間かきまぜ、次いで二硫化炭素3.25gを10分間
かけて適下する。1時間かきまぜた後、tert―ブ
トキシカリウム4.55gを少しづつ加え、さらに20
分間かきまぜ、ジクロロ酢酸カリウム6.83gを加
えて18時間かきまぜる。得られる反応液を減圧濃
縮し、酢酸エチル300mlと氷水200mlを加え、1規
定塩酸でPH3〜4にし、有機層を塩化ナトリウム
水溶液で洗浄後、飽和炭酸水素ナトリウム水溶液
1000mlで抽出する。この炭酸水素ナトリウム抽出
液を酢酸エチル100mlで洗浄し、5規定塩酸でPH
3〜4にした後、酢酸エチル200mlで抽出する。
この酢酸エチル抽出液を塩化ナトリウム水溶液で
洗浄し、無水硫酸ナトリウムで乾燥後濃緒する。
残留物をシリカゲルカラムクロマトグラフイーに
付し、溶離液として、最初にクロロホルム次いで
クロロホルム・メタノール混液(容量比50:1)
を用いて4―〔(5―メチルチオ―1,3,4―
チアジアゾール―2―イル)(tert―ブトキシカ
ルボニル)メチレン〕―1,3―ジチエタン―2
―カルボン酸1gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm);1.59(9H,(CH33COOC―) 2.79(3H,CH3S―) 4.99(1H,
[Formula]) Example 9 1.58g of metallic potassium in 100ml of tert-butanol
Add 10 g of tert-butyl 5-methylthio-1,3,4-thiadiazole-2-acetate to
Stir for a minute, then drop in 3.25 g of carbon disulfide over 10 minutes. After stirring for 1 hour, add 4.55 g of tert-butoxypotassium little by little, and add 20 g of tert-butoxypotassium little by little.
Stir for a minute, add 6.83 g of potassium dichloroacetate, and stir for 18 hours. The resulting reaction solution was concentrated under reduced pressure, 300 ml of ethyl acetate and 200 ml of ice water were added, the pH was adjusted to 3-4 with 1N hydrochloric acid, and the organic layer was washed with an aqueous sodium chloride solution, followed by a saturated aqueous sodium bicarbonate solution.
Extract with 1000ml. This sodium hydrogen carbonate extract was washed with 100ml of ethyl acetate, and the pH was adjusted with 5N hydrochloric acid.
After adjusting to 3-4, extract with 200 ml of ethyl acetate.
This ethyl acetate extract is washed with an aqueous sodium chloride solution, dried over anhydrous sodium sulfate, and concentrated.
The residue was subjected to silica gel column chromatography, using first chloroform and then a chloroform/methanol mixture (volume ratio 50:1) as the eluent.
using 4-[(5-methylthio-1,3,4-
Thiadiazol-2-yl)(tert-butoxycarbonyl)methylene]-1,3-dithiethane-2
- Obtain 1 g of carboxylic acid. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm); 1.59 (9H, (CH 3 ) 3 COOC—) 2.79 (3H, CH 3 S—) 4.99 (1H,

【式】) 実施例 10 水素化ナトリウム(油性50%)0.24gをベンゾ
イル酢酸tert―ブチル2.2gとtert―ブタノール20
mlの混液に溶かし、15〜20℃で二硫化炭素0.6ml
を加え、40分間かきまぜ、次いで水素化ナトリウ
ム(油性50%)0.24gを加えて1時間かきまぜ
る。得られる反応液にジクロロ酢酸ナトリウム
1.52gを加え、室温で4時間かきまぜた後減圧濃
縮し、残留物に1規定塩酸30mlを加えベンゼン30
mlで抽出する。抽出液を水洗し、乾燥後減圧濃縮
して得られる残留物にベンゼン・n―ヘキサン混
液(容量比3:1)を加えて4―〔(ベンゾイ
ル)(tertブトキシカルボニル)メチレン〕―
1,3―ジチエタン―2―カルボン酸の帯黄色結
晶0.9gを得る。 融点 147〜148℃(分解) 核磁気共鳴スペクトル(CDCl3) δ(ppm);1.23(9H,(CH33COOC―) 5.02(1H,
[Formula]) Example 10 0.24 g of sodium hydride (50% oily), 2.2 g of tert-butyl benzoyl acetate and 20 g of tert-butanol
ml of mixed solution and 0.6 ml of carbon disulfide at 15-20℃.
Add and stir for 40 minutes, then add 0.24 g of sodium hydride (50% oily) and stir for 1 hour. Add sodium dichloroacetate to the resulting reaction solution.
Add 1.52g of the mixture, stir at room temperature for 4 hours, concentrate under reduced pressure, add 30ml of 1N hydrochloric acid to the residue, and add 30ml of benzene.
Extract in ml. The extract was washed with water, dried, and then concentrated under reduced pressure. To the resulting residue, a mixed solution of benzene and n-hexane (volume ratio 3:1) was added to form 4-[(benzoyl)(tert-butoxycarbonyl)methylene]-
0.9 g of yellowish crystals of 1,3-dithiethane-2-carboxylic acid are obtained. Melting point 147-148℃ (decomposed) Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm); 1.23 (9H, (CH 3 ) 3 COOC—) 5.02 (1H,

【式】) 7.3〜7.5(5H,【formula】) 7.3~7.5 (5H,

【式】) 8.22(1H,―COOH) 実施例 11 n―ブチルリチウム15%含有ヘキサン溶液18.2
mlをジイソプロピルアミン3gとテトラヒドロフ
ラン20mlの混液に−40〜−70℃で加えることによ
り得られるリチウムジイソプロピルアミン溶液に
メトキシ酢酸tert―ブチル4.5gとテトラヒドロ
フラン10mlとの混液を加え、次いで二硫化炭素
0.9mlを−40℃以下で加えて同温度で20分間かき
まぜる。得られる反応液に−40〜−70℃で上記し
た1/2量のリチウムジイソプロピルアミン溶液
及び1/2量の二硫化炭素を加えて反応させた
後、さらに1/4量のリチウムジイソプロピルア
ミン溶液及び1/4量の二硫化炭素を加えて反応
させ、次いでジヨード酢酸ナトリウム9gを加え
徐々に温度を上げ、0〜5℃で1時間、さらに室
温で1時間かきまぜる。得られる反応液を減圧濃
縮し、残留物に10%塩酸20mlを加え、ベンゼン
100mlで抽出する。抽出液を水洗し、減圧濃縮し
て得られる残留物をシリカゲルカラムクロマトグ
ラフイーに付し、溶離液としてクロロホルム・エ
タノール混液(容量比10:2〜5)を用いて4―
〔(tert―ブトキシカルボニル)(メトキシ)メチ
レン〕―1,3―ジチエタン―2―カルボン酸
5.6gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.52(9H,(CH33COOC―) 3.67(3H,CH3O―) 4.88(1H,
[Formula]) 8.22 (1H, -COOH) Example 11 Hexane solution containing 15% n-butyllithium 18.2
ml of tert-butyl methoxyacetate and 10 ml of tetrahydrofuran was added to a lithium diisopropylamine solution obtained by adding 4.5 g of tert-butyl methoxyacetate and 10 ml of tetrahydrofuran to a mixture of 3 g of diisopropylamine and 20 ml of tetrahydrofuran at -40 to -70°C, and then carbon disulfide was added to the solution.
Add 0.9ml at -40℃ or below and stir at the same temperature for 20 minutes. After adding 1/2 amount of the above-mentioned lithium diisopropylamine solution and 1/2 amount of carbon disulfide to the resulting reaction solution at -40 to -70°C and reacting, add 1/4 amount of the lithium diisopropylamine solution. Then, 9 g of sodium diiodoacetate was added and the temperature was gradually raised, and the mixture was stirred at 0 to 5° C. for 1 hour and then at room temperature for 1 hour. The resulting reaction solution was concentrated under reduced pressure, 20 ml of 10% hydrochloric acid was added to the residue, and benzene was added.
Extract with 100ml. The extract was washed with water, concentrated under reduced pressure, and the resulting residue was subjected to silica gel column chromatography, using a chloroform/ethanol mixture (volume ratio 10:2-5) as the eluent.
[(tert-butoxycarbonyl)(methoxy)methylene]-1,3-dithiethane-2-carboxylic acid
Obtain 5.6g. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.52 (9H, (CH 3 ) 3 COOC—) 3.67 (3H, CH 3 O—) 4.88 (1H,

【式】) 8.64(1H,―COOH) 実施例 12 水素化ナトリウム(50%油性)0.96gを無水テ
トラヒドロフラン14mlに懸濁し、次いでtert―ブ
タノール20mlと無水テトラヒドロフラン15mlの混
液を適下して室温で10分間かきまぜる。これにメ
チルチオ酢酸tert―ブチル1.62gと無水テトラヒ
ドロフラン5mlとの混液を3〜5℃で加え30分後
に二硫化炭素0.6mlを同温で加えて50分間かきま
ぜる。次にジヨード酢酸ナトリウム3.34gを7℃
以下で加え、氷冷下で50分間反応させる。溶媒を
減圧留去し、残留物を氷水50mlに溶かしてエーテ
ルで2回洗浄する。水層を10%塩酸でPH2とし、
エーテルで2回抽出する。抽出液を合し、無水硫
酸マグネシウムで乾燥後、エーテルを減圧留去す
る。残留物をシリカゲルカラムクロマトグラフイ
ーに付し、溶離液としてクロロホルム・メタノー
ル・ギ酸混液(容量比95:5:2)を用いて油状
の4―〔(tert―ブトキシカルボニル)(メチルチ
オ)メチレン〕―1,3―ジチエタン―2―カル
ボン酸1.3gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.52(9H,(CH33COOC―) 2.22(3H,CH3S―) 4.74(1H,
[Formula]) 8.64 (1H, -COOH) Example 12 Suspend 0.96 g of sodium hydride (50% oil) in 14 ml of anhydrous tetrahydrofuran, then drop a mixture of 20 ml of tert-butanol and 15 ml of anhydrous tetrahydrofuran, and stir at room temperature for 10 minutes. A mixed solution of 1.62 g of tert-butyl methylthioacetate and 5 ml of anhydrous tetrahydrofuran was added to the mixture at 3 to 5° C. After 30 minutes, 0.6 ml of carbon disulfide was added at the same temperature and stirred for 50 minutes. Next, add 3.34 g of sodium diiodoacetate at 7°C.
Add the following and react for 50 minutes under ice cooling. The solvent was distilled off under reduced pressure, and the residue was dissolved in 50 ml of ice water and washed twice with ether. The aqueous layer was adjusted to pH 2 with 10% hydrochloric acid,
Extract twice with ether. The extracts are combined, dried over anhydrous magnesium sulfate, and then the ether is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and an oily 4-[(tert-butoxycarbonyl)(methylthio)methylene]- 1.3 g of 1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.52 (9H, (CH 3 ) 3 COOC—) 2.22 (3H, CH 3 S—) 4.74 (1H,

【式】) 9.12(1H,―COOH) 実施例 13 エチルチオ酢酸tert―ブチル3.4gを実施例12
と同様に処理することにより、油状の4―
〔(tert―ブトキシカルボニル)(エチルチオ)メ
チレン〕―1,3―ジチエタン―2―カルボン酸
4.05gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.42(3H,CH3 CH2S―) 1.52(9H,(CH33COOC―) 2.68(2H,CH3CH2 S―) 4.76(1H,
[Formula]) 9.12 (1H, -COOH) Example 13 Example 12: 3.4 g of tert-butyl ethylthioacetate
By processing in the same manner as above, oily 4-
[(tert-butoxycarbonyl)(ethylthio)methylene]-1,3-dithiethane-2-carboxylic acid
Obtain 4.05g. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.42 (3H, CH 3 CH 2 S—) 1.52 (9H, (CH 3 ) 3 COOC—) 2.68 (2H, CH 3 C H 2 S—) 4.76 (1H,

【式】) 9.52(1H,―COOH) 実施例 14 N―イソプロピルシクロヘキシルアミン1mlと
n―ブチルリチウム15%含有ヘキサン溶液3.43ml
とを予め蒸留して酸素を抜いたジメトキシエタン
40mlと無水テトラヒドロフラン10mlとの混液に窒
素気流中−70℃以下で加える。これにプロピオン
酸tert―ブチル0.65gを加え、−70℃以下で30分
間かきまぜ、次いで二硫化炭素0.332mlを−75〜
−73℃で30分かけて適下する。−70℃で10分間反
応させた後、n―ブチルリチウム15%含有ヘキサ
ン溶液3.4mlを同温度で30分間かけて適下する。
さらに同温度で15分間反応させた後、予め水素化
ナトリウム(50%油性)0.24gとジヨード酢酸
1.56gとをジメトキシエタン10ml中で氷冷下反応
させて得たジヨード酢酸ナトリウムを加え、室温
に戻して一夜かきまぜる。得られる反応液の溶媒
を減圧留去し、残留物に冷エーテルを加え1規定
塩酸で酸性にして抽出する。エーテル抽出液を冷
飽和塩化ナトリウム水溶液で洗浄し、無水硫酸マ
グネシウムで乾燥後、エーテルを留去して褐色油
状物1.42gを得る。これをシリカゲルカラムクロ
マトグラフイーに付し、溶離液としてクロロホル
ム・メタノール・ギ酸混液(容量比95:5:2)
を用いて油状の4―(1―tert―ブトキシカルボ
ニルエチリデン)―1,3―ジチエタン―2―カ
ルボン酸0.5gを得る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm):1.42(9H,(CH33COOC―) 1.53(3H,
[Formula]) 9.52 (1H, -COOH) Example 14 1ml of N-isopropylcyclohexylamine and 3.43ml of hexane solution containing 15% n-butyllithium
dimethoxyethane, which has been distilled in advance to remove oxygen.
Add to a mixture of 40 ml and 10 ml of anhydrous tetrahydrofuran at -70°C or below in a nitrogen stream. Add 0.65g of tert-butyl propionate to this, stir at -70℃ or below for 30 minutes, then add 0.332ml of carbon disulfide to -75~
Apply over 30 minutes at -73℃. After reacting at -70°C for 10 minutes, 3.4 ml of a hexane solution containing 15% n-butyllithium was added over 30 minutes at the same temperature.
After further reacting at the same temperature for 15 minutes, add 0.24 g of sodium hydride (50% oil) and diiodoacetic acid in advance.
Add sodium diiodoacetate obtained by reacting 1.56 g of 1.56 g with 1.56 g of dimethoxyethane under ice-cooling in 10 ml of dimethoxyethane, return to room temperature, and stir overnight. The solvent of the resulting reaction solution was distilled off under reduced pressure, and the residue was added with cold ether, acidified with 1N hydrochloric acid, and extracted. The ether extract was washed with cold saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and the ether was distilled off to obtain 1.42 g of a brown oil. This was subjected to silica gel column chromatography, and the eluent was a mixture of chloroform, methanol, and formic acid (volume ratio 95:5:2).
to obtain 0.5 g of oily 4-(1-tert-butoxycarbonylethylidene)-1,3-dithiethane-2-carboxylic acid. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 1.42 (9H, (CH 3 ) 3 COOC-) 1.53 (3H,

【式】) 5.14(1H,【formula】) 5.14 (1H,

【式】) 赤外スペクトル(cm-1) 2970((CH33C―),2520〜2650(―COOH) 1640〜1740((CH33COOC―,―COOH) 1360,1250,840((CH33C―) 実施例 15 N―イソプロピルシクロヘキシルアミン2mlと
n―ブチルリチウム15%含有ヘキサン溶液6.86ml
とを予め蒸留して酸素を抜いたジメトロキシエタ
ン80mlと無水テトラヒドロフラン2mlとの混液に
窒素気流中−70℃以下で加える。これに酢酸tert
―ブチル1.16gを適下し、−70℃以下で30分間か
きまぜ、次いで二硫化炭素0.664mlを−72℃以下
で30分間かけて加える。−70℃以下で20分間反応
させた後、n―ブチルリチウム15%含有ヘキサン
溶液6.8mlを−72℃以下で15分間かけて適下し、−
70℃以下で20分間反応させる。次に予め水素化ナ
トリウム(50%油性)0.48gとジヨード酢酸3.12
gとをジメトキシエタン15ml中で反応させて得た
ジヨード酢酸ナトリウムを加え、室温に戻して一
夜かきまぜる。得られる反応液の溶媒を減圧留去
し、残留物に1規定塩酸20mlを加え冷エーテル50
mlで抽出する。水層をさらに冷エーテル30mlで抽
出し、エーテル抽出液を合して飽和塩化ナトリウ
ム水溶液各30mlで2回洗浄し、無水硫酸マグネシ
ウムで乾燥後、エーテルを留去して褐色油状物3
gを得る。これをシリカゲルカラムクロマトグラ
フイーに付し、溶離液としてクロロホルム・メタ
ノール・ギ酸混液(容量比95:5:2)を用いて
4―(tert―ブトキシカルボニルメチレン)―
1,3―ジチエタン―2―カルボン酸0.564gを
得る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm):1.45(9H,(CH33COOC―) 5.03(1H,
[Formula]) Infrared spectrum (cm -1 ) 2970 ((CH 3 ) 3 C—), 2520 to 2650 (—COOH) 1640 to 1740 ((CH 3 ) 3 COOC—, —COOH) 1360, 1250, 840 ((CH 3 ) 3 C―) Example 15 2ml of N-isopropylcyclohexylamine and 6.86ml of a hexane solution containing 15% n-butyllithium
Add to a mixture of 80 ml of dimethoxyethane, which has been previously distilled to remove oxygen, and 2 ml of anhydrous tetrahydrofuran at -70°C or below in a nitrogen stream. Add tert acetic acid to this
-Drop 1.16 g of butyl, stir at -70°C or below for 30 minutes, then add 0.664 ml of carbon disulfide at -72°C or below over 30 minutes. After reacting at -70℃ or below for 20 minutes, 6.8ml of a hexane solution containing 15% n-butyllithium was added dropwise at -72℃ or below over 15 minutes.
Incubate for 20 minutes at 70℃ or below. Next, add 0.48 g of sodium hydride (50% oil-based) and 3.12 g of diiodoacetic acid in advance.
Add sodium diiodoacetate obtained by reacting the mixture with g in 15 ml of dimethoxyethane, return to room temperature, and stir overnight. The solvent of the resulting reaction solution was distilled off under reduced pressure, 20 ml of 1N hydrochloric acid was added to the residue, and 50 ml of cold ether was added.
Extract in ml. The aqueous layer was further extracted with 30 ml of cold ether, the ether extracts were combined, washed twice with 30 ml each of saturated sodium chloride aqueous solution, dried over anhydrous magnesium sulfate, and the ether was distilled off to form a brown oil.
get g. This was subjected to silica gel column chromatography, and 4-(tert-butoxycarbonylmethylene)-
0.564 g of 1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 1.45 (9H, (CH 3 ) 3 COOC-) 5.03 (1H,

【式】) 5.69(1H,【formula】) 5.69 (1H,

【式】) 実施例 16 メチルスルホニル酢酸tert―ブチル2.05gを
tert―ブタノール65mlに溶かし、tert―ブトキシ
カリウム1.32gを加えて5分間かきまぜる。これ
に二硫化炭素0.91gを適下し、5分間かきまぜた
後、tert―ブトキシカリウム1.32gを加えて1時
間かきまぜる。次いでジヨード酢酸3.8gとtert
―ブトキシカリウム1.32gを加えて一夜かきまぜ
る。得られる反応液の溶媒を減圧留去し、残留物
に水を加え、10%塩酸でPH2とし、酢酸エチルで
抽出する。抽出液を水、次いで飽和塩化ナトリウ
ム水溶液で洗浄し、無水硫酸マグネシウムで乾燥
後、溶媒を減圧留去する。残留物をシリカゲルカ
ラムクロマトグラフイーに付し、溶離液としてク
ロロホルム・メタノール混液(容量比50:1)を
用いて4―〔(tert―ブトキシカルボニル)(メチ
ルスルホニル)メチレン〕―1,3―ジチエタン
―2―カルボン酸1.7gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.52(9H,(CH33COOC―) 3.20(3H,CH3SO2―) 4.88(1H,
[Formula]) Example 16 2.05g of tert-butyl methylsulfonylacetate
Dissolve in 65 ml of tert-butanol, add 1.32 g of tert-butoxypotassium, and stir for 5 minutes. Add 0.91 g of carbon disulfide and stir for 5 minutes, then add 1.32 g of potassium tert-butoxy and stir for 1 hour. Then 3.8g of diiodoacetic acid and tert.
-Add 1.32g of butoxypotassium and stir overnight. The solvent of the resulting reaction solution was distilled off under reduced pressure, water was added to the residue, the pH was adjusted to 2 with 10% hydrochloric acid, and the mixture was extracted with ethyl acetate. The extract is washed with water and then with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography, and 4-[(tert-butoxycarbonyl)(methylsulfonyl)methylene]-1,3-dithiethane was extracted using a chloroform/methanol mixture (volume ratio 50:1) as the eluent. Obtain 1.7 g of -2-carboxylic acid. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.52 (9H, (CH 3 ) 3 COOC—) 3.20 (3H, CH 3 SO 2 —) 4.88 (1H,

【式】) 実施例 17 ジナトリウム2―カルバモイル―2―シアノ―
エチレン―1,1―ジチオレート4.8gをジメチ
ルスルホキシド50mlに溶かし、ジブロモ酢酸tert
―ブチル6.28gを加えて室温で48時間かきまぜ
る。得られる反応液の溶媒を減圧留去し、酢酸エ
チルで抽出する。抽出液を水、次いで塩化ナトリ
ウム水溶液で洗浄し、無水硫酸マグネシウムで洗
浄後、溶媒を減圧留去する。残留物をシリカゲル
カラムクロマトグラフイーに付し、溶離液として
クロロホルム・酢酸エチル混液(容量比7:1)
を用いて4―〔(カルバモイル)(シアノ)メチレ
ン〕―1,3―ジチエタン―2―カルボン酸tert
―ブチル0.8gを得る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm):1.47(9H,(CH33COOC―) 5.42(1H,
[Formula]) Example 17 Disodium 2-carbamoyl-2-cyano-
Dissolve 4.8 g of ethylene-1,1-dithiolate in 50 ml of dimethyl sulfoxide and add dibromoacetic acid tert.
-Add 6.28g of butyl and stir at room temperature for 48 hours. The solvent of the resulting reaction solution was distilled off under reduced pressure, and the mixture was extracted with ethyl acetate. The extract is washed with water, then with an aqueous sodium chloride solution, and then with anhydrous magnesium sulfate, and then the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography using a mixture of chloroform and ethyl acetate (volume ratio 7:1) as the eluent.
4-[(carbamoyl)(cyano)methylene]-1,3-dithiethane-2-carboxylic acid tert using
- Obtain 0.8 g of butyl. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 1.47 (9H, (CH 3 ) 3 COOC-) 5.42 (1H,

【式】) 実施例 18 アニソール2mlとトリフルオロ酢酸8mlとを実
施例17で得られた4―〔(カルバモイル)(シア
ノ)メチレン〕―1,3―ジチエタン―2―カル
ボン酸tert―ブチル0.4gに加え、室温で1時間
かきまぜる。溶媒を減圧留去し、残留物にエーテ
ル10mlを加えて1時間かきまぜる。生じた沈殿物
を取し、エーテルで洗浄後、減圧乾燥して4―
〔(カルバモイル)(シアノ)メチレン〕―1,3
―ジチエタン―2―カルボン酸0.15gを得る。 実施例 19 実施例17で得られた4―〔(カルバモイル)(シ
アノ)メチレン〕―1,3―ジチエタン―2―カ
ルボン酸tert―ブチル0.28gを塩化メチレン15ml
に加え、次いでピリジン0.33gと五塩化リン0.43
gを加えて室温で30分間かきまぜる。次にクロロ
ホルム30mlを加え、1規定硫酸、5%炭酸水素ナ
トリウム水溶液、飽和塩化ナトリウム水溶液で順
次洗浄し、無水硫酸マグネシウムで乾燥後、溶媒
を減圧留去する。残留物をシリカゲルカラムクロ
マトグラフイーに付し、溶離液としてクロロホル
ムを用いて4―ジシアノメチレン―1,3―ジチ
エタン―2―カルボン酸tert―ブチル0.23gを得
る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):1.54(9H,―COOC(CH33) 5.02(1H,
[Formula]) Example 18 2 ml of anisole and 8 ml of trifluoroacetic acid were added to 0.4 g of tert-butyl 4-[(carbamoyl)(cyano)methylene]-1,3-dithiethane-2-carboxylate obtained in Example 17, and the mixture was heated at room temperature for 1 hour. Stir. The solvent was distilled off under reduced pressure, 10 ml of ether was added to the residue, and the mixture was stirred for 1 hour. The resulting precipitate was collected, washed with ether, and dried under reduced pressure.
[(carbamoyl)(cyano)methylene]-1,3
0.15 g of -dithiethane-2-carboxylic acid is obtained. Example 19 0.28 g of tert-butyl 4-[(carbamoyl)(cyano)methylene]-1,3-dithiethane-2-carboxylate obtained in Example 17 was added to 15 ml of methylene chloride.
in addition to 0.33 g of pyridine and 0.43 g of phosphorus pentachloride.
Add g and stir at room temperature for 30 minutes. Next, 30 ml of chloroform is added, and the mixture is washed successively with 1N sulfuric acid, 5% aqueous sodium bicarbonate solution, and saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography using chloroform as an eluent to obtain 0.23 g of tert-butyl 4-dicyanomethylene-1,3-dithiethane-2-carboxylate. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 1.54 (9H, -COOC(CH 3 ) 3 ) 5.02 (1H,

【式】) 実施例 20 アニソール2mlとトリフルオロ酢酸6mlを実施
例19で得られた4―ジシアノメチレン―1,3―
ジチエタン―2―カルボン酸tert―ブチル0.23g
に加え、室温で3時間かきまぜる。溶媒を減圧留
去し、残留物にヘキサン10mlを加えて10分間かき
まぜる。溶媒をデカントして除いて得た残留物に
同じ操作を2度行い、減圧乾燥して4―ジシアノ
メチレン―1,3―ジチエタン―2―カルボン酸
0.18gを得る。 実施例 21 無水テトラヒドロフラン30mlとtert―ブタノー
ル20mlとをスルフアモイル酢酸ベンズヒドリル
1.12gに加え、−20℃に冷却して水素化ナトリウ
ム(50%油性)0.177gを加え15分間かきまぜ
る。これに二硫化炭素0.3gを加え、−10〜−5℃
で30分間かきまぜ、次いで水素化ナトリウム(50
%油性)0.354gとジヨード酢酸1.05gを加え、−
10〜0℃で20分間かきまぜた後、室温に戻して一
夜かきまぜる。得られる反応液の溶媒を減圧留去
し、残留物に氷水と5%塩酸を加えてPH2とし、
酢酸エチルで抽出する。抽出液を飽和塩化ナトリ
ウム水溶液で2回洗浄し、無水硫酸マグネシウム
で乾燥後、溶媒を減圧留去する。残留物をシリカ
ゲルカラムクロマトグラフイーに付し、溶離液と
してクロロホルム・メタノール混液(容量比10:
1)を用いて4―〔(ベンズヒドリルオキシカル
ボニル)(スルフアモイル)メチレン〕―1,3
―ジチエタン―2―カルボン酸0.2gを得る。 核磁気共鳴スペクトル(CDCl3) δ(ppm):4.66(1H,
[Formula]) Example 20 Add 2 ml of anisole and 6 ml of trifluoroacetic acid to 4-dicyanomethylene-1,3- obtained in Example 19.
tert-butyl dithiethane-2-carboxylate 0.23g
and stir at room temperature for 3 hours. The solvent is distilled off under reduced pressure, 10 ml of hexane is added to the residue, and the mixture is stirred for 10 minutes. The same operation was performed twice on the residue obtained by decanting the solvent and drying under reduced pressure to obtain 4-dicyanomethylene-1,3-dithiethane-2-carboxylic acid.
Obtain 0.18g. Example 21 Add 30 ml of anhydrous tetrahydrofuran and 20 ml of tert-butanol to benzhydryl sulfamoyl acetate.
In addition to 1.12 g, cool to -20°C, add 0.177 g of sodium hydride (50% oil-based), and stir for 15 minutes. Add 0.3g of carbon disulfide to this and -10 to -5℃
Stir for 30 minutes, then add sodium hydride (50
% oily) and 1.05 g of diiodoacetic acid, -
Stir at 10-0°C for 20 minutes, then return to room temperature and stir overnight. The solvent of the resulting reaction solution was distilled off under reduced pressure, and ice water and 5% hydrochloric acid were added to the residue to adjust the pH to 2.
Extract with ethyl acetate. The extract is washed twice with a saturated aqueous sodium chloride solution, dried over anhydrous magnesium sulfate, and then the solvent is distilled off under reduced pressure. The residue was subjected to silica gel column chromatography using a chloroform/methanol mixture (volume ratio 10:
1) using 4-[(benzhydryloxycarbonyl)(sulfamoyl)methylene]-1,3
0.2 g of -dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ (ppm): 4.66 (1H,

【式】) 6.96(1H,(C6H52C―) 7.33(10H,(C6 H5 2CH―) 実施例 22 15%(W/W)カリウムtert―ブトキシドの
tert―ブタノール溶液3ml中に室温で撹拌下N―
メチルマロナミン酸tert―ブチル540mgと乾燥テ
トラヒドロフラン12mlを加える。 5分間撹拌した後、二硫化炭素0.0935mlを適下
し、10分間撹拌する。又15%カリウムtert―ブト
キシドのtert―ブタノール溶液を1.5ml加え10分
間撹拌し、二硫化炭素0.046mlを適下10分間撹
拌、更に15%カリウム―tert―ブトキシドのtert
―ブタノール溶液0.8mlを加え10分間撹拌し、二
硫化炭素0.023mlを加え10分間撹拌する。 次に、前もつてジヨード酢酸0.98gを乾燥テト
ラヒドロフラン7mlにとかし、氷冷撹拌下50%ソ
ジウムハイドライド115mgを加えて作つたジヨー
ド酢酸ナトリウムのテトラヒドロフランけんだく
液を上の反応液に加えて室温で1時間撹拌して反
応を終る。溶媒を減圧下留去した後エーテル150
ml、0℃に冷却した0.2N―塩酸50mlを加え、エ
ーテルで抽出し、2回50mlの水で洗浄する。次に
エーテル層は2%炭酸水素ナトリウム水50mlで逆
抽出し、水層は1N―塩酸でPH約7.5に中和してエ
ーテル100mlで抽出する。水層は又1N―塩酸0.5
mlを加えエーテル100mlで抽出、又水層は1N―塩
酸0.5mlを加えエーテル100mlで抽出する。この操
作をくり返し行つて、エーテル抽出の各フラクシ
ヨンを薄層シリカゲルカラムクロマトグラフイー
に付し、アセトニトリル:酢酸エチル:水(混合
比3:1:1)の混合溶媒で展開して目的物を含
むフラクシヨンを集め、溶媒を減圧下留去してア
メ状の4―〔(tert―ブトキシカルボニル)(メチ
ルカルバモイル)メチレン〕―1,3―ジチエタ
ン―2―カルボン酸600mgを得た。 核磁気共鳴スペクトル(CDCl3) δ:1.52(9H,―C(CH3 ) 2.84(3H,―NHCH3 ) 4.83(1H,
[Formula]) 6.96 (1H, (C 6 H 5 ) 2 CH -) 7.33 (10H, (C 6 H 5 ) 2 CH -) Example 22 15% (W/W) potassium tert-butoxide
N- in 3 ml of tert-butanol solution at room temperature under stirring.
Add 540 mg of tert-butyl methylmalonamate and 12 ml of dry tetrahydrofuran. After stirring for 5 minutes, drop 0.0935 ml of carbon disulfide and stir for 10 minutes. Add 1.5 ml of 15% potassium tert-butoxide in tert-butanol and stir for 10 minutes. Add 0.046 ml of carbon disulfide and stir for 10 minutes, then add 15% potassium tert-butoxide in tert-butanol and stir for 10 minutes.
- Add 0.8 ml of butanol solution and stir for 10 minutes, then add 0.023 ml of carbon disulfide and stir for 10 minutes. Next, a suspension of sodium diiodoacetate in tetrahydrofuran, prepared by previously dissolving 0.98 g of diiodoacetic acid in 7 ml of dry tetrahydrofuran and adding 115 mg of 50% sodium hydride under stirring under ice cooling, was added to the above reaction solution, and the mixture was heated at room temperature. The reaction was completed by stirring for 1 hour. After distilling off the solvent under reduced pressure, ether 150
ml, add 50 ml of 0.2N hydrochloric acid cooled to 0°C, extract with ether, and wash twice with 50 ml of water. Next, the ether layer is back-extracted with 50 ml of 2% sodium bicarbonate water, and the aqueous layer is neutralized to pH approximately 7.5 with 1N hydrochloric acid and extracted with 100 ml of ether. The aqueous layer is also 1N-hydrochloric acid 0.5
ml and extracted with 100 ml of ether.For the aqueous layer, add 0.5 ml of 1N hydrochloric acid and extract with 100 ml of ether. By repeating this operation, each fraction of the ether extraction was subjected to thin-layer silica gel column chromatography and developed with a mixed solvent of acetonitrile: ethyl acetate: water (mixing ratio 3:1:1) to contain the target product. The fractions were collected and the solvent was distilled off under reduced pressure to obtain 600 mg of candy-like 4-[(tert-butoxycarbonyl)(methylcarbamoyl)methylene]-1,3-dithiethane-2-carboxylic acid. Nuclear magnetic resonance spectrum (CDCl 3 ) δ: 1.52 (9H, -C(CH 3 ) 3 ) 2.84 (3H, -NHC H 3 ) 4.83 (1H,

【式】) 実施例 23 ジメトキシエタン120ml、テトラハイドロフラ
ン30mlの混液を−74℃にドライアイス―アセトン
浴にて冷し、イソプロピルシクロヘキシルアミン
4.0mlを、次いでn―ブチルリチウム(15%n―
ヘキサン溶液)13.72mlを加える。(−73℃より−
62℃まで温度上昇した。) 酪酸tert―ブチル3.17gを加え30分間、−74〜
−75℃で反応させた後、二硫化炭素664μを約
10分要して適下して20分間その温度で反応させ
る。次いでn―ブチルリチウム(15%n―ヘキサ
ン溶液)6.86mlを−72℃以下約15分間で適下後、
30分間反応させた。二硫化炭素332μを10分間
要して同様に加え、20分間反応後、更にn―ブチ
ルリチウム(15%n―ヘキサン溶液)3.43mlを13
分間−72℃以下で適下後20分−74〜−73℃で反応
させた。又、二硫化炭素166μを6分間−74℃
前後で加えた。約25分反応後、予めジメトキシエ
タン25ml中、50%ソジウムハイドライド0.84gと
ジヨード酢酸5.46gから作つたジヨード酢酸ナト
リウム塩を加える。添加後0〜+5℃で30分間反
応させた後、室温にて一夜反応させた。溶媒を減
圧で留去した残渣に冷エーテル50mlと冷1N―塩
酸水溶液40mlを加え抽出する。得たエーテル層を
飽和炭酸水素ナトリウム水各20mlで二回抽出し水
層を得る。更に水層を1N―塩酸にてPH1として
エーテル30ml、20mlで二回抽出後、水洗、無水硫
酸マグネシウムにて乾燥後、エーテルを留去して
オイル状生成物1.08gを得た。 この油状物をシリカゲルカラムクロマトグラフ
イー〔クロロホルム:メタノール=10:1混合溶
媒にて流出〕で目的物を含むフラクシヨンを集め
れば褐色オイル状の4―〔(tert―ブトキシカル
ボニル)(エチル)メチレン〕―1,3―ジチエ
タン―2―カルボン酸630mgを得る。 核磁気共鳴スペクトル(CDCl3) δ:1.24(3H,t,―CH3 ) 1.47(9H,s,―C(CH3 ) 2.01(2H,q,―C ― 4.87(1H,S,
[Formula]) Example 23 Cool a mixture of 120 ml of dimethoxyethane and 30 ml of tetrahydrofuran to -74°C in a dry ice-acetone bath, and add isopropylcyclohexylamine.
4.0 ml, then n-butyllithium (15% n-
Add 13.72ml (hexane solution). (from −73℃−
The temperature rose to 62℃. ) Add 3.17 g of tert-butyl butyrate and heat for 30 minutes, -74~
After reacting at -75℃, approximately 664μ of carbon disulfide was added to the
It takes 10 minutes to drop and react at that temperature for 20 minutes. Next, after dropping 6.86 ml of n-butyllithium (15% n-hexane solution) at -72℃ or less for about 15 minutes,
The reaction was allowed to proceed for 30 minutes. 332μ of carbon disulfide was added in the same manner over 10 minutes, and after 20 minutes of reaction, 3.43ml of n-butyllithium (15% n-hexane solution) was added for 13 minutes.
After dropping at -72°C or lower for 20 minutes, the reaction was carried out at -74 to -73°C. Also, 166μ of carbon disulfide was heated at -74℃ for 6 minutes.
Added before and after. After about 25 minutes of reaction, diiodoacetic acid sodium salt previously prepared from 0.84 g of 50% sodium hydride and 5.46 g of diiodoacetic acid in 25 ml of dimethoxyethane is added. After the addition, the mixture was reacted for 30 minutes at 0 to +5°C, and then overnight at room temperature. The solvent was distilled off under reduced pressure, and 50 ml of cold ether and 40 ml of cold 1N hydrochloric acid aqueous solution were added to the residue for extraction. The obtained ether layer was extracted twice with 20 ml each of saturated sodium bicarbonate water to obtain an aqueous layer. Further, the aqueous layer was adjusted to pH 1 with 1N hydrochloric acid, extracted twice with 30 ml and 20 ml of ether, washed with water, dried over anhydrous magnesium sulfate, and the ether was distilled off to obtain 1.08 g of an oily product. If this oily substance is subjected to silica gel column chromatography (emitted using a mixed solvent of chloroform:methanol = 10:1) and the fraction containing the target product is collected, a brown oily 4-[(tert-butoxycarbonyl)(ethyl)methylene] is obtained. 630 mg of -1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (CDCl 3 ) δ: 1.24 (3H, t, -C H 3 ) 1.47 (9H, s, -C (C H 3 ) 3 ) 2.01 (2H, q, -C H 2 - 4.87 (1H ,S,

【式】) 実施例 24 ジナトリウム2―tert―ブトキシカルボニル―
2―シアノエチレン―1,1―ジチオレート3.3
gとジクロロ酢酸1.0gとをテトラヒドロフラン
10mlに懸濁させ、氷冷下ナトリウムハイドライド
372mgを加える。添加後氷浴を取り去り、室温で
2時間かきまぜる。反応終了後溶媒を減圧留去
し、残留物に水5mlを加えて溶かし、希塩酸でPH
3.5〜4としてエーテルで抽出する。抽出液を無
水硫酸マグネシウムで乾燥後溶媒を留去すると、
4―(tert―ブトキシカルボニルシアノメチレ
ン)―1,3―ジチエタン―2―カルボン酸0.5
gを得る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm):1.44(9H,(CH33COOC―) 5.46(1H,
[Formula]) Example 24 Disodium 2-tert-butoxycarbonyl-
2-cyanoethylene-1,1-dithiolate 3.3
g and 1.0 g of dichloroacetic acid in tetrahydrofuran.
Suspend in 10 ml of sodium hydride under ice cooling.
Add 372 mg. After addition, remove the ice bath and stir at room temperature for 2 hours. After the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 5 ml of water, and the pH was adjusted with dilute hydrochloric acid.
Extract with ether as 3.5-4. After drying the extract over anhydrous magnesium sulfate and distilling off the solvent,
4-(tert-butoxycarbonylcyanomethylene)-1,3-dithiethane-2-carboxylic acid 0.5
get g. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 1.44 (9H, (CH 3 ) 3 COOC-) 5.46 (1H,

【式】) 実施例 25 4―(アセチルtert―ブトキシカルボニルメチ
レン)―1,3ジチエタン―2―カルボン酸3g
をメチレンクロリド30mlに溶かし、この溶液にジ
フエニルジアゾメタン2.42gをメチレンクロリド
5mlに溶かした溶液を氷冷下適下する。適下後室
温で20分間かきまぜる。反応液を濃縮後、シリカ
ゲルカラムクロマトグラフイーに付し、クロロホ
ルム:n―ヘキサン混液(容量比4:1)で溶出
すると、4―(アセチルtert―ブトキシカルボニ
ルメチレン)―1,3ジチエタン―2―カルボン
酸ベンズヒドリル3gを得る。ついで4―(アセ
チルtert―ブトキシカルボニルメチレン)―1,
3―ジチエタン―2―カルボン酸ベンズヒドリル
3gにトリフルオロ酢酸24mlとアニソール6mlと
の混液を氷冷下加える。ついで室温で1時間30分
かきまぜた後濃縮し、石油エーテルを加えて粉末
化し、過する。これをエーテル200mlに溶か
し、濃緒後メチレンクロリド2mlを加えて過す
ると、4―(アセチルカルボキシメチレン)―
1,3―ジチエタン―2―カルボン酸1.3gを得
る。 核磁気共鳴スペクトル(DMSO―d6) δ(ppm):2.39(3H,H3COC―) 5.22(1H,
[Formula]) Example 25 4-(acetyl tert-butoxycarbonylmethylene)-1,3 dithiethane-2-carboxylic acid 3g
was dissolved in 30 ml of methylene chloride, and a solution of 2.42 g of diphenyldiazomethane dissolved in 5 ml of methylene chloride was added dropwise to this solution under ice cooling. After applying, stir at room temperature for 20 minutes. After concentrating the reaction solution, it was subjected to silica gel column chromatography and eluted with a chloroform:n-hexane mixture (volume ratio 4:1) to yield 4-(acetyl tert-butoxycarbonylmethylene)-1,3 dithiethane-2- 3 g of benzhydryl carboxylate are obtained. Then 4-(acetyl tert-butoxycarbonylmethylene)-1,
Add a mixture of 24 ml of trifluoroacetic acid and 6 ml of anisole to 3 g of benzhydryl 3-dithiethane-2-carboxylate under ice cooling. After stirring at room temperature for 1 hour and 30 minutes, the mixture was concentrated, powdered with petroleum ether, and filtered. Dissolve this in 200 ml of ether, add 2 ml of methylene chloride and filter. 4-(acetylcarboxymethylene)-
1.3 g of 1,3-dithiethane-2-carboxylic acid is obtained. Nuclear magnetic resonance spectrum (DMSO-d 6 ) δ (ppm): 2.39 (3H, H 3 COC-) 5.22 (1H,

【式】)【formula】)

Claims (1)

【特許請求の範囲】 1 一般式 〔式中R1はカルボキシル基、シアノ基、ベンズヒ
ドリルオキシカルボニル基又は低級アルコキシカ
ルボニル基を、R2は水素原子、シアノ基、カル
ボキシル基、スルフアモイル基、ビニル基、置換
されていてもよいカルバモイル基、低級アルキル
基、低級アルコキシ基、アロイル基、置換されて
いてもよいアリール基、置換されていてもよい単
環複素環基、RCO―又はR―S(O)o―(式中
Rは低級アルコキシ基、又は水酸基を有していて
もよくまたヘテロ原子で中断されていてもよい低
級アルキル基を、nは0,1又は2を表わす。)
で示される基を、R3は水素原子又は低級アルキ
ル基を表わす。〕 で示される1,3―ジチエタン化合物。 2 一般式 (式中R1とR2は前記と同じ意味を表わす。)で示
されるエチレンジチオール化合物と 一般式 (式中Xはハロゲン原子を表わし、R3は前記と同
じ意味を表わす。) で示されるジハロゲノ酢酸化合物とを反応させる
ことを特徴とする一般式 (式中R1、R2及びR3は前記と同じ意味を表わ
す。)で示される1,3―ジチエタン化合物の製
造法。
[Claims] 1. General formula [In the formula, R 1 is a carboxyl group, a cyano group, a benzhydryloxycarbonyl group, or a lower alkoxycarbonyl group, and R 2 is a hydrogen atom, a cyano group, a carboxyl group, a sulfamoyl group, a vinyl group, or an optionally substituted carbamoyl group. group, lower alkyl group, lower alkoxy group, aroyl group, optionally substituted aryl group, optionally substituted monocyclic heterocyclic group, RCO- or R-S(O) o- (wherein R is (n represents a lower alkoxy group or a lower alkyl group which may have a hydroxyl group or may be interrupted by a hetero atom; n represents 0, 1 or 2)
In the group represented by, R 3 represents a hydrogen atom or a lower alkyl group. ] A 1,3-dithiethane compound represented by: 2 General formula (In the formula, R 1 and R 2 have the same meanings as above.) An ethylenedithiol compound represented by the general formula (In the formula, X represents a halogen atom, and R 3 represents the same meaning as above.) A general formula characterized by reacting with a dihalogenoacetic acid compound represented by A method for producing a 1,3-dithiethane compound represented by the formula (wherein R 1 , R 2 and R 3 have the same meanings as above).
JP1951278A 1977-07-28 1978-02-22 1,3-dithiethane compound and its preparation Granted JPS54112867A (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
JP1951278A JPS54112867A (en) 1978-02-22 1978-02-22 1,3-dithiethane compound and its preparation
GB25352/78A GB1604738A (en) 1977-07-28 1978-05-31 1,3-dithietane-2-carboxylic acid derivatives and the preparation thereof
DE2824575A DE2824575C2 (en) 1977-07-28 1978-06-05 4-substituted methylene-1,3-dithietane-2-carboxylic acid or its lower alkyl esters, processes for their preparation and their use as acylating agents
CH610878A CH636098A5 (en) 1977-07-28 1978-06-05 1,3-DITHIETANE-2-CARBONIC ACIDS AND METHOD FOR THE PRODUCTION THEREOF.
US05/913,501 US4198339A (en) 1977-07-28 1978-06-07 1,3-Dithietane-2-carboxylic acids and the preparation thereof
FR7817304A FR2398745A1 (en) 1977-07-28 1978-06-09 DITHIETANE-1,3-CARBOXYLIC-2 AND PROCESS FOR PREPARATION
IT68370/78A IT1109095B (en) 1977-07-28 1978-06-12 ACIDS 1.3 DITIETAN 2 CARBOXYLS AND PROCEDURE FOR THEIR PREPARATION
US06/304,986 US4414153A (en) 1977-07-28 1981-09-23 1,3-Dithietane-2-carboxylic acid penicillin and cephalosporin derivatives
US07/449,114 USRE33778E (en) 1977-07-28 1989-12-08 1,3-dithietane-2-carboxylic acid penicillin and cephalosporin derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1951278A JPS54112867A (en) 1978-02-22 1978-02-22 1,3-dithiethane compound and its preparation

Publications (2)

Publication Number Publication Date
JPS54112867A JPS54112867A (en) 1979-09-04
JPS6154031B2 true JPS6154031B2 (en) 1986-11-20

Family

ID=12001409

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1951278A Granted JPS54112867A (en) 1977-07-28 1978-02-22 1,3-dithiethane compound and its preparation

Country Status (1)

Country Link
JP (1) JPS54112867A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0274714A (en) * 1988-09-12 1990-03-14 Yamazaki Kensetsu Kk Mold smoothing device of earth and sand

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0274714A (en) * 1988-09-12 1990-03-14 Yamazaki Kensetsu Kk Mold smoothing device of earth and sand

Also Published As

Publication number Publication date
JPS54112867A (en) 1979-09-04

Similar Documents

Publication Publication Date Title
JP2004043482A (en) Carboxylic acid derivative
HU219464B (en) Ethinyl substituted chroman and thiochroman derivatives and method for producing
JPH05208978A (en) Method for aroylating 5-position of 1,2-dihydro-3h-pyrrolo(1,2-alpha)pyrrole-1-carboxyic ester
DE2824575C2 (en) 4-substituted methylene-1,3-dithietane-2-carboxylic acid or its lower alkyl esters, processes for their preparation and their use as acylating agents
JPH013173A (en) Method for producing oxophthalazinyl acetic acids having a heterocyclic side chain such as benzothiazole
EP0312269B1 (en) 3,5-dihydroxy-6,8-nonadienoic acids and derivatives as hypocholesterolemic agents
JPS6154031B2 (en)
Turck et al. Diazines. IX. Metalation of 2‐chloro, 2‐methoxy and 2‐pivaloylaminoquinoxaline
JPH07103105B2 (en) Indole derivative and method for producing the same
JPS647072B2 (en)
JP3231207B2 (en) Method for producing sulfenylacetic acid derivative
JPH0378384B2 (en)
JPH0647570B2 (en) Carboxamide derivative
KR100502833B1 (en) Improved preparation method of simvastatin and their intermediates
JPH064625B2 (en) Substituted isoquinoline derivative and anti-ulcer agent
JP4264144B2 (en) Indene derivatives
JP2005126340A (en) Method for producing substituted pyridone compounds, raw material compound thereof and method for producing the same
JP2005068036A (en) Method for producing substituted pyridones, raw material compound thereof and method for producing the same
JPH06211780A (en) Benzoyl cyanide derivative, its production and reaction using the same
JP3303132B2 (en) Bis-disulphide compound and method for producing the same
JP4060718B2 (en) New production method of enol ether
JPS634546B2 (en)
JPS6242907B2 (en)
JPS6145619B2 (en)
JPH01207271A (en) Production of 4-hydroxyoligopyridines